📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Clinical impact of plasma concentrations of first-line antituberculosis drugs. (2023)

First Author: Perumal R

Attributed to: Addressing challenges in scaling up TB and HIV treatment integration in public health settings in South Africa funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.7196/samj.2023.v113i3.16761

PubMed Identifier: 36876350

Publication URI: http://europepmc.org/abstract/MED/36876350

Type: Journal Article/Review

Volume: 113

Parent Publication: South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde

Issue: 3